Cue Biopharma Inc
CUE
NASDAQ
Biotechnology
$34.20
USD
+3.12 (+10.04%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $131.26M
Volume 156.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics Inc | $163.15M | - | - | - | |
CBUS | Cibus Inc | $148.47M | - | -9.8% | - | |
UNCY | Unicycive Therapeutics Inc | $137.24M | - | - | - | |
SPRB | Spruce Biosciences, Inc | $136.98M | - | - | - | |
IMDX | Insight Molecular Diagnostics Inc | $131.55M | - | -49.3% | - | |
CUE | Cue Biopharma Inc | $131.26M | - | +309.6% | - | |
EQ | Equillium Inc | $127.40M | - | - | - | |
VTVT | vTv Therapeutics Inc | $125.18M | 55.59 | +216600.0% | - | |
GNLX | Genelux Corp | $121.97M | - | - | - | |
INDP | Indaptus Therapeutics Inc | $120.04M | - | - | - |
Top Peer by Growth
vTv Therapeutics Inc
+216600.0% YoY Revenue
Lowest P/E Ratio
vTv Therapeutics Inc
55.59x P/E
Best 1-Year Return
Spruce Biosciences, Inc
+423.0% Return